Clinical Trials Directory

Trials / Unknown

UnknownNCT01460563

Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia

Effects of Valproic Acid and Magnesium Sulphate on Rocuronium Requirement and Postoperative Analgesia in Patients Undergoing Craniotomy for Cerebrovascular Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesized that valproic acid will increase rocuronium requirement and MgSO4 infusion would reduce requirement of muscle relaxant in craniotomy patients preloaded with sodium valproate.

Detailed description

Magnesium sulfate (MgSO4) is known to reduce requirement of muscle relaxant.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium SulfateMgSO4 infusion: 50mg/kg bolus followed by continuous infusion
DRUG0.9% saline0.9% saline as same dose as MgSO4 as placebo
DRUG0.9% saline0.9% saline as same dose as MgSO4 as placebo

Timeline

Start date
2011-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-10-27
Last updated
2011-12-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01460563. Inclusion in this directory is not an endorsement.